Heron Therapeutics (HRTX) Q2 2026 Earnings

11MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.1
-0.06
-0.03
0.01

Details

Expected EPS
-0.023333
Actual EPS
-0.04
Surprise EPS
-0.02
Surprise Percent
+71.43%

Description

Heron Therapeutics (HRTX) has reported earnings of -0.04 per share for Q2 2026.

0 Comments

Share your thoughts